Loading clinical trials...
Loading clinical trials...
Assessing the safety, efficacy and pharmacokinetics of SPP100 (Aliskiren) regimen in hypertensive patients with renal dysfunction
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis
NCT07481981 · Pulmonary Arterial Hypertension
NCT07606859 · Hypertension Arterial, 65 Years Older
NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more
NCT07578090 · Hypertension, Cardiovascular Disease, and more
NCT07280390 · Cirrhosis, Microplastics, and more
Novartis Pharmaceuticals
Japan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions